SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-034775
Filing Date
2020-06-05
Accepted
2020-06-05 18:06:15
Documents
2
Period of Report
2020-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6025
2 POA DOCUMENT poa.txt EX-24.4_920393 3175
  Complete submission text file 0001209191-20-034775.txt   10630
Mailing Address 890 WINTER STREET WALTHAM MA 02451
Business Address
BIGHAM MICHAEL (Reporting) CIK: 0001216917 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36399 | Film No.: 20947575

Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Issuer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations